Quorum Therapeutics - New Therapeutic Class. For the greatest unmet need in Staphylococcal infections: pneumonia and sepsis (lead indication). Novel mode of action is a unique therapeutic approach. Stops bacteria from causing damage, the first disease-modifying treatment. Anti-Virulence Therapeutics - clears the infection, reduces inflammation, protects tissue and organs. Current round – $550K confirms IV delivery – $350K secured (65% done)